3Stroup SP,Palazzi-Churas K,Kopp RP. Trends in adverse events of benign prostatic hyperplasia (BPH) in the USA,1998 to 2008[J].British Journal of Urology International,2012,(01):84-87.
4Chen IH,Tsai YS,Tong YC. Correlations among cardiovascular risk factors,prostate blood flow,and prostate volume in patients with clinical benign prostatic hyperplasia[J].Urology,2012,(02):409-414.
5Malaeb BS,Yu X,McBean AM. National Trends in Surgical Therapy for Benign Prostatic Hyperplasia in the United States (2000-2008)[J].Urology,2012,(05):1111-1116.
6McVary KT,Roehrborn CG,Avins AL. Update on AUA guideline on the management of benign prostatic hyperplasia[J].The Journal of Urology,2011,(05):1793-1803.